The study of renin-angiotensin-aldosterone in experimental diabetes mellitus

Cell Biochemistry and Function

Volumn 17, Issue 3, 1999, Pages 193-198

  Üstündag, Bilal ^a   Cay, M ^a   Naziroglu, M ^a   Dilsiz, N ^a   Crabbe, M J C ^b   Ilhan, N ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Angiotensin converting enzyme (ACE); Diabetes mellitus (DM); Streptozotocin (STZ)

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; STREPTOZOCIN;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR DISEASE;

ALDOSTERONE; ANGIOTENSINS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RENIN; RENIN-ANGIOTENSIN SYSTEM;

ANIMALIA;

EID: 0343401865     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0844(199909)17:3<193::AID-CBF828>3.0.CO;2-N     Document Type: Article

References (25)

1. Cooper, M. E., Rumble, J. R., Gin, T. and Lim-Joon, T. (1992). Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors., Clin. Exp. Pharmacol. Physiol., 19(Supp), 23-27.
2. Trujillo, A., Eggena, P., Barret, J. and Tuck, M. (1989). Renin regulation in type II diabetes mellitus: influence of dietary sodium. Hypertension, 13, 200-205.
3. Johnston, C. I., Fabris, B. and Jandeleit, K. (1993). Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney International, 44, S59-S63.
4. Buttery, J. E. and Stuart, S. (1993). Studies on zinc angiotensin-converting enzyme. Clinica Chimica Acta, 217, 213-216.
5. Linz, W., Wiemer, G. and Schölkens, B. A. (1996). Role of kinins in the pathophysiology of myocardial ischemia. Diabetes, 45, S51-S58.
6. Allen, T. J., Cao, Z., Youssef, S., Hulthen, U. L. and Cooper, M. E. (1997). Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes, 46, 1612-1618.
7. Sraer, J. D., Kanfer, A., Rondeau, E. and Lacave, R. (1989). Role of the renin-angiotensin system in the regulation of glomerular filtration. J. Cardiovasc. Pharmacol., 14, S21-S25.
8. Ekmekçi, A. (1995). Insulin Resistance, Hypertension and Antyhypertensive Treatment. Roche Publications: Istanbul, Turkey, pp. 5-11.
9. Perez, G. O., Lespior, L. and Levin, L. (1977). Selective hyporenininism and hypoaldosteronism in diabetes mellitus. Arch. Intern. Med., 137, 852-855.
10. Blumenfeld, J. D. (1994). The complications of hypertension of kidney and heart. Clinical Symposia, 46, 4-12.
11. De Cotret, P. R. (1998). Relationships among diabetes, microalbuminuria, and ACE inhibition. J. Cardiovasc. Pharmacol., 32, S9-17.
12. Ciavarella, A., Mustacchio, A., Ricci, C., Capelli, M. and Vannini, P. (1994). Enhanced pressor responsiveness to norepinephrine in type II diabetes. Effects of ACE inhibition. Diabetes Care, 17, 1484-1488.
13. Keane, W. F., Anderson, S., Aurell, M., Dezeeuw, D., Narins, R. G. and Pover, G. (1989). Angiotensin converting enzyme inhibitors and progressive renal insufficiency: current experience and future directions. Annals of Internal Medicine, 111, 503-516.
14. Valentovic, M. A., Elliot, C. W. and Ball, J. G. (1987). The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res. Comm. Chem. Path. Pharmacol., 58, 27-39.
15. Holmquist, B., Bunning, P. and Riordan, J. F. (1979). A continuous spectrophotometric assay for angiotensin converting enzyme. Analytical. Biochem., 95, 540.
16. Rerup, C. W. (1970). Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Review, 22, 485-518.
17. Chriestlieb, A. and Richard, M. D. (1976). Renin-angiotensin-aldosterone system in diabetes mellitus. Diabetes, 25, 820-825.
18. Luetscher, J. A., Kraemer, F. G., Wilson, D. M., Schwartz, H. C. and Bryer-Ash, M. (1985). Increased plasma inactive renin in diabetes mellitus. New England J. Med., 312, 1412-1417.
19. Scherthaner, G., Schwarzer, C., Kuzmits, R., Muller, M. M., Klemen, U. and Freyler, H. (1984). Increased angiotensin converting enzyme activities in diabetes mellitus: Analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease. J. Clin. Pathol., 37, 307-312.
20. Funakawa, S., Okahara, T., Imanishi, M., Komoro, T., Yamamoto, K. and Tochino, Y. (1983). Renin angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats. European J. Pharmacol., 94, 27-33.
21. Parving, H. H. (1998). Is antihyperlensive treatment the same for NIDDM and IDDM patients? Diabetes Res. Clin. Practice, 39, S43-47.
22. Ahmad, J., Siddiqui, M. A. and Ahmad, H. (1997). Effetive postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Diabetes Care, 20, 1576-81.
23. Hartmann, J. K., Szemplenski, M., Hayes, N. S., Keegan, M. E. and Slater, E. E. (1988). Effects of angiotensin converting enzyme inhibitor lizinopril on normal and diabetic rats. J. Hypertension, 6, 677-683.
24. De Chatel, R., Weidmann, P., Flammer, J., Ziegler, W. H., Piccoli-Carlo, B. and Vetter, W. (1977). Sodium renin, aldosterone, catecholainines, and blood pressure in diabetes mellitus. Kidney International, 12, 412-421.
25. Kohler, E., Boilatt, N., Luthi, P., Atkinson, J. and PetersHaefeli, E. (1980). Influence of streptozotocin-induced diabetes on blood pressure and on renin formation and release. Naunyn-Schmiedeberg's Archives Pharmacol., 313, 257-261.